SEC Form 4 · accession 0001127602-17-025677
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard J Meelia
Director
Period of report
Aug 10, 2017
Accepted (ET)
Aug 15, 2017 · 7:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2017 | M | 16,968 | $32.96 | A | 43,879 | D | |
| Common Stock | Aug 10, 2017 | S | 16,968 | $42.02 | D | 26,911 | D | |
| Common Stock | Aug 10, 2017 | M | 7,118 | $34.405 | A | 34,029 | D | |
| Common Stock | Aug 10, 2017 | S | 7,118 | $42.1046 | D | 26,911 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy) | $32.96 | Aug 10, 2017 | M | 16,968 | D | Jun 3, 2012 | Jun 3, 2018 | Common Stock | 16,968 | 0 | D |
| Non-qualified Stock Option (Right to Buy) | $34.405 | Aug 10, 2017 | M | 7,118 | D | Jul 21, 2012 | Jul 21, 2018 | Common Stock | 7,118 | 0 | D |
Explanation of responses
- F1Represents the exercise and sale of stock options which expire in June 2018.
- F2Represents the exercise and sale of stock options which expire in July 2018.